The Food and Drug Administration has authorized pills to treat COVID-19. The agency issued emergency approval on Wednesday for an antiviral developed by Pfizer. The FDA's authorization allows high ...

SpringWorks aims to develop the four Pfizer drugs, and also plans to expand its ... Senicapoc (PF-05416266) for the rare genetic disorder, hereditary xerocytosis (HX), where red blood cells ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Conservative commentator Megyn Kelly claimed the Pfizer COVID vaccine left her with an auto-immune disorder in explosive new comments on her latest podcast episode Wednesday. Kelly, 54 ...

(Reuters) -Pfizer on Thursday named James List as the ... candidate along with those that treat heart conditions and blood disorders. The drugmaker said in January it would go "all in" to develop ...

Beqvez was developed in partnership with the now Roche-owned Spark Therapeutics and is one of two gene therapies manufactured by Pfizer for the bleeding disorder. The US big pharma company also ...

NEW YORK/TOKYO -- Pfizer will end global development and commercialization of Beqvez, a gene therapy for hemophilia, after the drugmaker dropped its other similar treatment for the disorder in ...